Long non-coding RNA: a versatile regulator of the nuclear factor-κB signalling circuit

Area of Science:

• Molecular Biology
• Immunology
• Genetics

Background:

• The nuclear factor-kappa B (NF-κB) pathway is crucial for inflammatory responses, immune function, and cell growth.
• Dysregulation of NF-κB signaling is implicated in inflammation, autoimmune diseases, and cancer.
• Current therapeutic strategies targeting NF-κB are limited by pathway complexity and lack of specificity.

Purpose of the Study:

• To review recent advancements in understanding long non-coding RNA (lncRNA)-mediated regulation of the NF-κB pathway.
• To evaluate the therapeutic potential and challenges associated with targeting lncRNAs involved in NF-κB signaling.

Main Methods:

• Literature review focusing on lncRNA-NF-κB interactions.
• Analysis of recent research on lncRNA functions in NF-κB modulation.
• Evaluation of therapeutic implications and challenges.

Main Results:

• lncRNAs represent a critical regulatory layer in the NF-κB signaling network.
• Specific lncRNAs have been identified that can either activate or inhibit NF-κB.
• These lncRNAs offer potential as novel therapeutic targets.

Conclusions:

• lncRNAs provide a new avenue for modulating NF-κB activity.
• Targeting lncRNAs may overcome limitations of current NF-κB therapies.
• Further research is needed to fully realize the therapeutic potential of lncRNAs in NF-κB-related diseases.